Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases

CaSR Biomedicine

The calcium sensing receptor (CaSR) is a class C Gprotein-coupled receptor that plays a pivotal role in systemic calcium metabolism by regulating parathyroid hormone secretion and urinary Ca excretion. Abnormal CaSR function is implicated in calciotropic disorders, and in non-calciotropic disorders such as Alzheimer’s disease (AD), cardiovascular...

Funding Programme
Start Date
End Date
Total Funding
€ 3 657 195

Co-designing a Home with Dementia

HOMEDEM

The Doctoral Network “Co-designing a Home with Dementia” (HOMEDEM) is a Marie-Skłodowska-Curie Actions' Innovative Training Network that will provide high-level training in design and dementia caregiving, to high achieving, early-stage researchers. HOMEDEM focuses on the recent move across Europe towards supporting people with dementia (PwD) living...

Funding Programme
Start Date
End Date
Total Funding
€ 2 122 747
European Countries Involved

Computational Intelligence in Lifestyle Management Infrastructure

CILMI

Influenced by the developments in information and communication technologies and pressured by the dramatic changes in demographics in our societies, health care is and must be transforming to remain viable and of high quality. An important element in such changing health care is the emergence of personal health systems. Based on smart home...

Funding Programme
Start Date
End Date
Total Funding
€ 205 200
European Countries Involved

Connecting to the Networks of the Human Brain

ConnectToBrain

ConnectToBrain will introduce whole-brain multi-locus transcranial magnetic stimulation (mTMS), in which the brain-stimulating electric-field location, direction, magnitude and timing are controlled electronically based on real-time high-density electroencephalography (hdEEG) information of activity and connectivity in brain networks. The final...

Funding Programme
Start Date
End Date
Total Funding
€ 9 981 794
European Countries Involved

Coordination Action in support of the implementation of a Joint Programming Initiative for Combating Neurodegenerative Diseases, in particular Alzheimer’s disease

JUMPAHEAD

The objective of the Coordination Action JUMPAHEAD is to support the implementation of the pilot Joint Programming Initiative on combating neurodegenerative diseases, in particular Alzheimer’s disease (JPND). Neurodegenerative disorders are incurable and debilitating conditions that result in progressive degeneration or death of nerve cells. Of...

Funding Programme
Start Date
End Date
Total Funding
€ 2 618 090

CryoEm structure of gamma secretase: a key component in Alzheimer neurodegenerative disease

RENZI_FP7_IOF2007

Alzheimer disease (AD) is characterised by the accumulation of beta amyloid peptide cut from a transmembrane precursor. A large intramembrane complex carries out the proteolysis: gamma-secretase, containing the protease presenilin and other three proteins (nicastrin, aph1, pen2). G-secretase is involved also in the proteolysis mediated signaling...

Funding Programme
Start Date
End Date
Total Funding
€ 238 305
European Countries Involved

Data-driven models for Progression Of Neurological Disease

EuroPOND

EuroPOND will develop a data-driven statistical and computational modeling framework for neurological disease progression. This will enable major advances in differential and personalized diagnosis, prognosis, monitoring, and treatment and care decisions, positioning Europe as world leaders in one of the biggest societal challenges of 21st century...

Funding Programme
Start Date
End Date
Total Funding
€ 5 498 612
European Countries Involved

Deep-Learning and HPC to Boost Biomedical Applications for Health

DeepHealth

Health scientific discovery and innovation are expected to quickly move forward under the so called “fourth paradigm of science”, which relies on unifying the traditionally separated and heterogeneous high-performance computing and big data analytics environments. Under this paradigm, the DeepHealth project will provide HPC computing power at the...

Funding Programme
Start Date
End Date
Total Funding
€ 14 642 324
European Countries Involved

Designing for People with Dementia: designing for mindful self-empowerment and social engagement

MinD

This project aims to help people with dementia engage in social contexts to improve psychosocial wellbeing. People who are affected by Alzheimer’s disease or other dementias often face cognitive, behavioural and psychosocial difficulties, including impairment and degeneration of memory and of perceptions of identity. In a social context, this can...

Funding Programme
Start Date
End Date
Total Funding
€ 549 000
European Countries Involved

Developing new therapies for Batten disease

BATCure

The goal of BATCure is to advance the development of new therapeutic options for a group of rare lysosomal diseases - neuronal ceroid lipofuscinoses (NCL) or Batten disease. There are > thousand affected across Europe, with a combined incidence of c.1:100 000. The NCLs are devastating and debilitating genetic disorders that mainly affect children...

Funding Programme
Start Date
End Date
Total Funding
€ 6 000 681
European Countries Involved

Development of a Novel Multicellular In Vitro Model of Alzheimer’s disease-like Blood-Brain Barrier

NAB3

A striking challenge in diagnosis and therapy of neurodegenerative diseases is the design of drugs capable of crossing the blood-brain barrier (BBB), a tightly regulated barrier that prevents the passage of drugs from the blood to the brain. In vitro cellular BBB models are available, but they mimic only healthy conditions without taking into...

Funding Programme
Start Date
End Date
Total Funding
€ 812 488
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).